Pathophysiology and clinical presentation of paediatric heart failure related to congenital heart disease.
congenital heart disease
paediatric heart failure
pathophysiology
Journal
Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
26
04
2021
received:
22
01
2021
accepted:
30
04
2021
pubmed:
6
5
2021
medline:
6
8
2021
entrez:
5
5
2021
Statut:
ppublish
Résumé
Congenital heart disease (CHD) and cardiomyopathies represent the two most important causes of paediatric heart failure (HF) in developed countries. We made a review of the literature on pathophysiology and clinical presentation of paediatric HF in children with CHD. Two main pathophysiologic models can be identified: the 'over-circulation failure', characterised by signs and symptoms of congestion or hypoperfusion, due respectively to volume or pressure overload, and the 'pump failure'. CONCLUSIONS: The comprehension of the HF pathophysiology in paediatric patients with CHD is of paramount importance for the optimal management and for addressing the best therapeutic choices.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2336-2343Informations de copyright
©2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Références
Kirk R, Dichpand AI, Rosenthal DN, et al. The international Society of Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant. 2014;33:888-909.
Kantor PF, Lougheed J, Dancea A, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2013;29:1535-1552.
Hsu DT, Pearson GD. Heart failure in children. Part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63-70.
Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13:368-378.
Shaddy RE, George AT, Jaecklin T, et al. Systematic literature review on incidence and prevalence of heart failure in children and adolescents. Pediatr Cardiol. 2018;39:415-436.
Rossano JW, Kim JJ, Decker JA, et al. Prevalence, morbidity, and mortality of heart failure-related hospitalization in children in the United State: a population based study. J Card Fail. 2012;18:459-470.
Andrews RE, Fenton MJ, Ridout DA, Burch M. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation. 2008;117:79-84.
Neumann T, Biermann J, Erbel R, et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztbel Int. 2009;106:269-275.
Schmidt S, Hendricks V, Griebenow R, Riedel R. Demographic change and its impact on the health-care budget for heart failure inpatients in Germany during 1995-2009. Herz. 2013;38:862-867.
Massin MM, Astadicko I, Dessy H. Epidemiology of heart failure in a tertiary pediatric center. Clin Cardiol. 2008;31:388-391.
Rodriguez-Rieiro C, Dominguez-Berjon MF, Esteban-Vasallo MD, et al. Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: analysis of population registries in primary care in Madrid (Spain). Vaccine. 2010;28:6203-6209.
Jimenez-Garcia R, Esteban-Vasallo MD, Rodriguez-Rieiro C, et al. Coverage and predictors of vaccination against 2012/13 seasonal influenza in Madrid, Spain: analysis of population-based computerized immunization registries and clinical records. Hum Vaccin Immunother. 2014;10:449-455.
Tomlinson TW, Scott CH, Trotman HL. Congenital cardiovascular lesions in children with trisomy 21 at the Bustamante Hospital for Children. Cardiol Young. 2010;20:327-331.
Okoromah CA, Ekure EN, Lesi FE, Okunowo WO, Tijani BO, Okeiyi JC. Prevalence, profile and predictors of malnutrition in children with congenital heart defects: a case-control observational study. Arch Dis Child. 2011;96:354-360.
Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012;33:1295-1300.
Ross RD. Grading the graders of congestive heart failure in children. J Pediatr. 2001;138:618-620.
Kantor PF, Mertens LL. Heart failure in children. Part I: clinical evaluation, diagnostic testing and initial clinical management. Eur J Pediatr. 2010;169:269-279.
Das BB. Current state of pediatric heart failure. Children. 2018;5(7):88.
Favilli S, Prandstraller D, Spaziani G, et al. Age related issues in heart failure: from fetus to the adolescent. Prog Pediatr Cardiol. 2018;51:3-7.
Jarmakani MM, Graham TP, Canent RV, Spach MS, Capp MP. Effect site of shunt on the left heart-volume characteristics in children with ventricular septal defect and patent ductus arteriosus. Circulation. 1969;40:441-448.
Graham TP, Atwood GF, Boucek RJ, Cordell D, Boerth RC. Right ventricular volume characteristics in ventricular septal defect. Circulation. 1976;54:800-804.
Buchhorn R, Ross RD, Bartmus D, Wessel A, Hulpke-Wette M, Bursh J. Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. Int J Cardiol. 2001;78:225-230.
Nir A, Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail. 2005;11:S76-S80.
Stewart JM, Hintze TH, Woolf PK, Snyder MS, Seligman KP, Gewitz MH. Nature of heart failure in patients with ventricular septal defect. Am J Physiol. 1995;269:1473-1480.
Rudolph AM. Congenital Diseases of the Heart: Clinical-Physiological Considerations. Chicago, IL: Wiley-Blackwell; 1974.
Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams' Heart Disease in Infants, Children, and Adolescents. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
Bagtharia R, Trivedi KR, Burkhart HM, et al. Outcomes for patients with an aortopulmonary window, and the impact of associated cardiovascular lesions. Cardiol Young. 2004;14:473-480.
Hundscheid T, Onland W, Van Overmeire B, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicenter, randomized, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr. 2018;18(1):262.
Friedman WF. Neonatal Heart Disease. New York, NY: Grune and Stratton; 1972.
Perez Fontan JJ, Clyman RI, Mauray F, Heymann MA, Roman C. Respiratory effects of a patent ductus arteriosus in premature newborn lambs. J Appl Physiol. 1987;63(6):2315-2324.
Anderson RH, Baker EJ, Penny DJ, Redington AN, Rigby ML, Wernovsky G. Paediatric Cardiology, (Chapter 34, p 720). Philadelphia, PA: Churchill Livingstone; 2010.
Jaquiss RD, Imamura M. Management of Ebstein's anomaly and pure tricuspid insufficiency in the neonate. Semin Thorac Cardiovasc Surg. 2007;19:258-263.
Kwiatkowski DM, Hanley FL, Krawczeski CD. Right ventricular outflow tract obstruction: pulmonary atresia with intact septum, pulmonary stenosis, and Ebstein's malformation. Pediatr Crit Care Med. 2016;17:S323-S329.
Brown ML, Dearani JA. Ebstein malformation of the tricuspid valve: current concepts in management and outcomes. Curr Treat Options Cardiovasc Med. 2009;11:396-402.
Zucker N, Rozin I, Levitas A, Zalzstein E. Clinical presentation, natural history, and outcome of patients with the absent pulmonary valve syndrome. Cardiol Young. 2004;14:402-408.
Lakier JB, Stanger P, Heymann MA, Hoffman JIE, Rudolph AM. Tetralogy of Fallot with absent pulmonary valve. Natural history and hemodynamic considerations. Circulation. 1974;50:167-175.
Guccione P, Iorio FS, Rebonato M, et al. Profiles of heart failure in adolescents and young adults with congenital heart disease. Prog Pediatr Cardiol. 2018;51:37-45.
Ganeshalingham A, Finucane K, Hornung T. Isolated congenital mitral valve regurgitation presenting in the first year of life. J Paediatr Child Health. 2010;46:159-165.
Morse RP, Rockenmacher S, Pyeritz PE, et al. Diagnosis and management of infantile Marfan syndrome. Pediatrics. 1990;86:888-895.
Krieger EV, Fernandes SM. Heart failure caused by congenital left-sided lesions. Heart Failure Clin. 2014;10:155-165.
Jashari H, Rydberg A, Ibrahimi P, Bajraktari G, Henein MY. Left ventricular response to pressure afterload in children: aortic stenosis and coarctation. A systematic review of the current evidence. Int J Cardiol. 2015;178:203-209.
Broderick TW, Higgins CH, Guthaner DF, Friedman WF, Stevenson JG, French JW. Critical aortic stenosis in neonates. Radiology. 1978;129:393-399.
Lakier JB, Kewis AB, Heymann MA, Stanger P, Hoffman JIE, Rudoplh AM. Isolated aortic stenosis in the neonate: natural history and hemodynamic considerations. Circulation. 1974;50:801-808.
O'Brien P, Marshall AC. Coarctation of the aorta. Circulation. 2015;131:e363-e365.
Rigby ML. Severe aortic or pulmonary valve stenosis in premature infants. Early Hum Dev. 2012;88:291-294.
Sommer RJ, Rhodes JF, Parness IA. Physiology of critical pulmonary valve obstruction in the neonate. Catheter Cardiovasc Interv. 2000;50:473-479.
Stout KK, Broberg CS, Book WM, et al. Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133:770-801.
Iyengar AJ, Winlaw DS, Galati JC, et al. The extracardiac conduit Fontan procedure in Australia and New Zeland: hypoplastic left heart syndrome predicts worse early and late outcomes. Eur J Cardiothorac Surg. 2014;46:465-473.
Ono M, Kasnar-Samprec J, Hager A, et al. Clinical outcome following total cavopulmonary connection: a 20-year single-centre experience. Eur J Cardiothorac Surg. 2016;50:632-641.
de Leval MR, Deanfield JE. Four decades of Fontan palliation. Nat Rev Cardiol. 2010;7(9):520-527.
Kirklin JK, Pearce FB, Dabal RJ, Waldemar FC, Mauchley DC. Challenges of cardiac transplantation following the Fontan procedure. World J Pediatr Congenit Heart Surg. 2017;8(4):480-486.
Dennis M, Zannino D, du Plessis K, et al. Clinical outcomes in adolescents and adults after the Fontan procedure. J Am Coll Cardiol. 2018;71:1009-1017.
Bland E, White P, Garland J. Congenital anomalies of the coronary arteries. Am Heart J. 1993;8:797-801.
Perez-Pomares JM, de la Pompa JL, Franco D, et al. Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology-a position statement of the development, anatomy, and pathology ESC Working Group. Cardiovasc Res. 2016;109:204-216.
Silverman NH. Echocardiographic presentation of anomalous origin of the left coronary artery from the pulmonary artery. Cardiol Young. 2015;25:1512-1523.
Rowe GG, Young WP. Anomalous origin of the coronary arteries with special reference to surgical treatment. J Thorac Cardiov Surg. 1960;39:777-780.
Wesselhoeft H, Fawcett JS, Johnson AL. Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with severe further cases. Circulation. 1968;38:403-425.
Serio P, Chiappa E, Fainardi V, et al. ALCAPA and massive pulmonary atelectasis: how a stent in the airway can be life-saving. J Pediatr Otorhinolaryngol. 2014;78:2015-2017.
Kutty S, Danford DA, Diller GP, Tutarel O. Contemporary management and outcomes in congenitally corrected transposition of the great arteries. Heart. 2018;104:1148-1155.
Brida M, Diller GP, Gatzoulis MA. Systemic right ventricle in adults with congenital heart disease anatomic and phenotypic spectrum and current approach to management. Circulation. 2018;137:508-518.
Filippov AA, del Nido PJ, Vasilyev NV. Management of systemic right ventricular failure in patients with congenitally corrected transposition of the great arteries. Circulation. 2016;134:1293-1302.
Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation. 1983;67(6):1374-1377.
Vejlstrup N, Sørensen K, Mattsson E, et al. Long-term outcome of Mustard/Senning correction for transposition of the great arteries in Sweden and Denmark. Circulation. 2015;132:633-638.